OBJECTIVE: Acute leukemias (ALs) are rare but aggressive malignancies. The goal of our study was to determine the incidence and maternal and fetal outcomes of pregnancies afflicted by ALs. STUDY DESIGN: We performed a retrospective population-based cohort study on all births reported in the Health-care Cost and Utilization Project-Nationwide Inpatient Sample between 1999 and 2014. Using ICD9 codes, we established a cohort of births to women affected by ALs during pregnancy and compared it to a control group of unaffected deliveries. We calculated the incidence of ALs in pregnancy and conducted multivariate logistic regression to obtain adjusted odds ratios for several maternal and fetal outcomes among this population compared to a non-affected one. RESULTS: We identified 291 maternal cases of ALs among 14 513 587 births, yielding an incidence of 2.01 per 100,000 births over the 16-year study period. There were approximately twice as many diagnoses of acute myeloid leukemia as compared to acute lymphoblastic leukemia. Pregnant women with ALs were more likely to be Caucasian, to deliver at an urban teaching hospital, and to have medicare. After adjusting for differing baseline characteristics and maternal and fetal deaths, we found that pregnant women with ALs were more likely to experience post-partum hemorrhage (OR 2.42, 95% CI 1.55-3.79), to suffer from disseminated intravascular coagulation (OR 24.85, , to require transfusions (OR 54.43, , to have wound complications (OR 4.73, 95% CI 2.23-10.03), and to experience venous thromboembolisms (OR 10.09, ). Maternal death (OR 284.63, ), preterm delivery (OR 2.42, 95% CI 1.74-3.36), and intrauterine fetal death (OR 3.72, 95% CI 1.65-8.39) were also more common in pregnant patients with ALs. CONCLUSION: The incidence of ALs in pregnancy appears to be greater than what was previously believed. As it is associated with several adverse maternal and fetal outcomes, affected patients should be cared for in tertiary care institutions with access to high risk obstetrical specialists, hematologists, and neonatologists. Measures should be established to be adequately prepared for and try to mitigate the potential obstetrical emergencies and complications that may arise in this population.
730 Gestational age at delivery of twins and the risk of perinatal death: population cohort study OBJECTIVE: Twin pregnancy is associated with a threefold increase in perinatal mortality compared to singleton pregnancies. The aim of this study is to determine the week of gestation associated with the lowest risk of perinatal death in twins to inform clinicians regarding timing of delivery. STUDY DESIGN: A population based cohort study was performed with all twin pregnancies delivered at 34 weeks' gestation or greater from 1980-2015 in Scotland using routinely collected data. The primary outcome was perinatal mortality.To determine the association between gestation and perinatal death compared to ongoing pregnancies univariate and multivariate random effects modelling was performed.The study was approved by NHS Scotland Privacy Panel.
RESULTS:
The study population comprised of 43 436 twin infants with a total of 472 stillbirths and neonatal deaths. 303 infants were excluded due to unreliable gestational age and outliers leaving a cohort of 43 133 twins (fig 1) . Twin infants born at 34 weeks had an increased risk of perinatal death compared to ongoing pregnancies (adjusted odds ratio [OR], 3.27, 95% CI 2.34 e 4.57) as did delivery at 35 and 36 weeks (adjusted ORs 2.06 and 1.34, table 1). Delivery at 37 and 38 weeks were associated with lower risk of perinatal death compared to ongoing pregnancies (adjusted OR 0.52, 95% CI 0.37 e 0.71 and adjusted OR 0.50, 95% CI 0.36 e 0.69 respectively). CONCLUSION: Gestation at delivery has a strong relationship with perinatal death. Twins born at 37 weeks' gestation had lower rates of perinatal death compared to ongoing pregnancies. This information should be used when counselling women. To our knowledge this is the largest UK cohort study of twins.
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